rs11205362
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004698.4(PRPF3):c.146-17G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,609,420 control chromosomes in the GnomAD database, including 9,760 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.082 ( 678 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9082 hom. )
Consequence
PRPF3
NM_004698.4 intron
NM_004698.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.404
Publications
16 publications found
Genes affected
PRPF3 (HGNC:17348): (pre-mRNA processing factor 3) The removal of introns from nuclear pre-mRNAs occurs on complexes called spliceosomes, which are made up of 4 small nuclear ribonucleoprotein (snRNP) particles and an undefined number of transiently associated splicing factors. This gene product is one of several proteins that associate with U4 and U6 snRNPs. Mutations in this gene are associated with retinitis pigmentosa-18. [provided by RefSeq, Jul 2008]
PRPF3 Gene-Disease associations (from GenCC):
- retinitis pigmentosa 18Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 1-150325734-G-A is Benign according to our data. Variant chr1-150325734-G-A is described in ClinVar as Benign. ClinVar VariationId is 1165123.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0819 AC: 12449AN: 151974Hom.: 678 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
12449
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0839 AC: 21101AN: 251456 AF XY: 0.0842 show subpopulations
GnomAD2 exomes
AF:
AC:
21101
AN:
251456
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.106 AC: 154364AN: 1457328Hom.: 9082 Cov.: 32 AF XY: 0.104 AC XY: 75563AN XY: 725126 show subpopulations
GnomAD4 exome
AF:
AC:
154364
AN:
1457328
Hom.:
Cov.:
32
AF XY:
AC XY:
75563
AN XY:
725126
show subpopulations
African (AFR)
AF:
AC:
582
AN:
33334
American (AMR)
AF:
AC:
2133
AN:
44604
Ashkenazi Jewish (ASJ)
AF:
AC:
2531
AN:
25936
East Asian (EAS)
AF:
AC:
2
AN:
39536
South Asian (SAS)
AF:
AC:
2810
AN:
85980
European-Finnish (FIN)
AF:
AC:
7638
AN:
53160
Middle Eastern (MID)
AF:
AC:
422
AN:
5662
European-Non Finnish (NFE)
AF:
AC:
132299
AN:
1109074
Other (OTH)
AF:
AC:
5947
AN:
60042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
7116
14231
21347
28462
35578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
4672
9344
14016
18688
23360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0818 AC: 12445AN: 152092Hom.: 678 Cov.: 32 AF XY: 0.0810 AC XY: 6026AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
12445
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
6026
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
859
AN:
41492
American (AMR)
AF:
AC:
1030
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
AC:
334
AN:
3470
East Asian (EAS)
AF:
AC:
4
AN:
5184
South Asian (SAS)
AF:
AC:
141
AN:
4816
European-Finnish (FIN)
AF:
AC:
1638
AN:
10570
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8216
AN:
67992
Other (OTH)
AF:
AC:
141
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
584
1167
1751
2334
2918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
140
280
420
560
700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
66
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.